{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:56:28Z","timestamp":1778633788210,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2003,8,21]],"date-time":"2003-08-21T00:00:00Z","timestamp":1061424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,8,21]],"date-time":"2003-08-21T00:00:00Z","timestamp":1061424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2003,11,1]]},"DOI":"10.1038\/sj.leu.2403124","type":"journal-article","created":{"date-parts":[[2003,8,20]],"date-time":"2003-08-20T20:26:54Z","timestamp":1061411214000},"page":"2101-2106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes"],"prefix":"10.1038","volume":"17","author":[{"given":"S","family":"Yazji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F J","family":"Giles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A-M","family":"Tsimberidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E H","family":"Estey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H M","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S A","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Kurzrock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,8,21]]},"reference":[{"key":"BF2403124_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189\u2013199.","journal-title":"Br J Haematol"},{"key":"BF2403124_CR2","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/0145-2126(95)00130-1","volume":"20","author":"E Abruzzese","year":"1996","unstructured":"Abruzzese E, Buss D, Rainer R, Rao PN, Pettanati MJ . Study of clonality in myelodysplastic syndromes: detection of trisomy 8 in bone marrow cell smears by fluorescence in situ hybridization. Leukemia Res 1996; 20: 551\u2013557.","journal-title":"Leukemia Res"},{"key":"BF2403124_CR3","first-page":"662","volume":"10","author":"P Bernell","year":"1996","unstructured":"Bernell P, Jacobsson B, Nordgren A, Hast R . Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology. Leukemia 1996; 10: 662\u2013668.","journal-title":"Leukemia"},{"key":"BF2403124_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/1097-0142(19830701)52:1<83::AID-CNCR2820520117>3.0.CO;2-9","volume":"52","author":"B Coiffier","year":"1983","unstructured":"Coiffier B, Adeleine P, Viala JJ, Bryon PA, Fiere D, Gentilhomme O et al . Dysmyelopoietic syndromes. A search for prognostic factors in 193 patients. Cancer 1983; 52: 83\u201390.","journal-title":"Cancer"},{"key":"BF2403124_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/1097-0142(19850801)56:3<553::AID-CNCR2820560323>3.0.CO;2-Q","volume":"56","author":"K Foucar","year":"1985","unstructured":"Foucar K, Langdon II RM, Armitage JO, Olson DB, Carroll Jr TJ . Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases. Cancer 1985; 56: 553\u2013561.","journal-title":"Cancer"},{"key":"BF2403124_CR6","first-page":"953","volume":"15","author":"GJ Mufti","year":"1986","unstructured":"Mufti GJ, Galton DA . Myelodysplastic syndromes: natural history and features of prognostic importance. Clin Haematol 1986; 15: 953\u2013971.","journal-title":"Clin Haematol"},{"key":"BF2403124_CR7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood.V74.1.395.395","volume":"74","author":"GF Sanz","year":"1989","unstructured":"Sanz GF, Sanz MA, Vallespi T, Canizo MC, Torrabadella M, Garcia S et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 1989; 74: 395\u2013408.","journal-title":"Blood"},{"key":"BF2403124_CR8","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1056\/NEJM199905273402107","volume":"340","author":"ML Heaney","year":"1999","unstructured":"Heaney ML, Golde DW . Myelodysplasia. N Engl J Med 1999; 340: 1649\u20131660.","journal-title":"N Engl J Med"},{"key":"BF2403124_CR9","first-page":"985","volume":"5","author":"R Kurzrock","year":"1991","unstructured":"Kurzrock R, Talpaz M, Estey E, O'Brien S, Estrov Z, Gutterman JU . Erythropoietin treatment in patients with myelodysplastic syndrome and anemia. Leukemia 1991; 5: 985\u2013990.","journal-title":"Leukemia"},{"key":"BF2403124_CR10","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1200\/JCO.2001.19.21.4165","volume":"19","author":"R Kurzrock","year":"2001","unstructured":"Kurzrock R, Cortes J, Thomas DA, Jeha S, Pilat S, Talpaz M . Pilot study of low-dose interleukin-11 in patients with bone marrow failure. J Clin Oncol 2001; 19: 4165\u20134172.","journal-title":"J Clin Oncol"},{"key":"BF2403124_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1365-2141.1991.tb08573.x","volume":"77","author":"EH Estey","year":"1991","unstructured":"Estey EH, Kurzrock R, Talpaz M, McCredie KB, O'Brien S, Kantarjian HM et al. Effects of low doses of recombinant human granulocyte\u2013macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromes. Br J Haematol 1991; 77: 291\u2013295.","journal-title":"Br J Haematol"},{"key":"BF2403124_CR12","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1182\/blood.V82.3.737.737","volume":"82","author":"RS Negrin","year":"1993","unstructured":"Negrin RS, Stein R, Vardiman J, Doherty K, Cornwell J, Krantz S et al. Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin. Blood 1993; 82: 737\u2013743.","journal-title":"Blood"},{"key":"BF2403124_CR13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood.V73.1.31.31","volume":"73","author":"A Ganser","year":"1989","unstructured":"Ganser A, Volkers B, Greher J, Ottmann OG, Walther F, Becher R et al. Recombinant human granulocyte\u2013macrophage colony-stimulating factor in patients with myelodysplastic syndromes \u2013 a phase I\/II trial. Blood 1989; 73: 31\u201337.","journal-title":"Blood"},{"key":"BF2403124_CR14","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1056\/NEJM198712173172501","volume":"317","author":"S Vadhan-Raj","year":"1987","unstructured":"Vadhan-Raj S, Keating M, LeMaistre A, Hittelman WN, McCredie K, Trujillo JM et al. Effects of recombinant human granulocyte\u2013macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N Engl J Med 1987; 317: 1545\u20131552.","journal-title":"N Engl J Med"},{"key":"BF2403124_CR15","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1182\/blood.V87.10.4076.bloodjournal87104076","volume":"87","author":"RS Negrin","year":"1996","unstructured":"Negrin RS, Stein R, Doherty K, Cornwell J, Vardiman J, Krantz S et al. Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy. Blood 1996; 87: 4076\u20134081.","journal-title":"Blood"},{"key":"BF2403124_CR16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1046\/j.1365-2141.1997.4013211.x","volume":"99","author":"E Hellstrom-Lindberg","year":"1997","unstructured":"Hellstrom-Lindberg E, Negrin R, Stein R, Krantz S, Lindberg G, Vardiman J et al. Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model. Br J Haematol 1997; 99: 344\u2013351.","journal-title":"Br J Haematol"},{"key":"BF2403124_CR17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1182\/blood.V92.1.68.413k23_68_75","volume":"92","author":"E Hellstrom-Lindberg","year":"1998","unstructured":"Hellstrom-Lindberg E, Ahlgren T, Beguin Y, Carlsson M, Carneskog J, Dahl IM et al. Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythro-poietin: results from a randomized phase II study and long-term follow-up of 71 patients. Blood 1998; 92: 68\u201375.","journal-title":"Blood"},{"key":"BF2403124_CR18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1600-0609.1987.tb00008.x","volume":"38","author":"T Economopoulos","year":"1987","unstructured":"Economopoulos T, Stathakis N, Foudoulakis A, Papadoulis N, Dervenoulas J, Papageorgiou E et al. Myelodysplastic syndromes: analysis of 131 cases according to the FAB classification. Eur J Haematol 1987; 38: 338\u2013344.","journal-title":"Eur J Haematol"},{"key":"BF2403124_CR19","first-page":"1805","volume":"9","author":"T de Witte","year":"1995","unstructured":"de Witte T, Suciu S, Peetermans M, Fenaux P, Strijckmans P, Hayat M et al. Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG). Leukemia 1995; 9: 1805\u20131811.","journal-title":"Leukemia"},{"key":"BF2403124_CR20","first-page":"1","volume":"5","author":"M Talpaz","year":"2001","unstructured":"Talpaz M, Zhang F, Kurzrock R . Myelodysplastic syndromes. Hemato\u2013Oncol Clin Manage Modules 2001; 5: 1\u201327.","journal-title":"Hemato\u2013Oncol Clin Manage Modules"},{"key":"BF2403124_CR21","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1182\/blood.V90.8.2969","volume":"90","author":"E Estey","year":"1997","unstructured":"Estey E, Thall P, Beran M, Kantarjian H, Pierce S, Keating M . Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia (AML)) on outcome of AML-type chemotherapy. Blood 1997; 90: 2969\u20132977.","journal-title":"Blood"},{"key":"BF2403124_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1053\/shem.2002.35981","volume":"39","author":"R Kurzrock","year":"2002","unstructured":"Kurzrock R . Myelodysplastic syndrome overview. Semin Hematol 2002; 39: 18\u201325.","journal-title":"Semin Hematol"},{"key":"BF2403124_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bmt.1703610","volume":"30","author":"S Luger","year":"2002","unstructured":"Luger S, Sacks N . Bone marrow transplantation for myelodysplastic syndrome \u2013 who? when? and which? Bone Marrow Transplant 2002; 30: 199\u2013206.","journal-title":"Bone Marrow Transplant"},{"key":"BF2403124_CR24","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1200\/JCO.2002.04.117","volume":"20","author":"LR Silverman","year":"2002","unstructured":"Silverman LR, Demakos EP, Peterson BL, Kornblith AB, Holland JC, Odchimar-Reissig R et al. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J Clin Oncol 2002; 20: 2429\u20132440.","journal-title":"J Clin Oncol"},{"key":"BF2403124_CR25","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1056\/NEJM199105093241901","volume":"324","author":"N Frickhofen","year":"1991","unstructured":"Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F et al. Treatment of aplastic anemia with antithymocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med 1991; 324: 1297\u20131304.","journal-title":"N Engl J Med"},{"key":"BF2403124_CR26","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood.V85.11.3058.bloodjournal85113058","volume":"85","author":"SJ Rosenfeld","year":"1995","unstructured":"Rosenfeld SJ, Kimball J, Vining D, Young NS . Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 1995; 85: 3058\u20133065.","journal-title":"Blood"},{"key":"BF2403124_CR27","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1182\/blood.V72.6.1861.1861","volume":"72","author":"N Young","year":"1988","unstructured":"Young N, Griffith P, Brittain E, Elfenbein G, Gardner F, Huang A et al. A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases. Blood 1988; 72: 1861\u20131869.","journal-title":"Blood"},{"key":"BF2403124_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0037-1963(00)90027-1","volume":"37","author":"J Barrett","year":"2000","unstructured":"Barrett J, Saunthararajah S, Molldrem J . Myelodysplastic syndrome and aplastic anemia: Distinct entities or diseases linked by a common pathophysiology? Semin Hematol 2000; 37: 15\u201329.","journal-title":"Semin Hematol"},{"key":"BF2403124_CR29","first-page":"3671","volume":"96","author":"BD Cheson","year":"2000","unstructured":"Cheson BD, Bennett JM, Kantarjian H, Pinto A, Schiffer CA, Nimer SD et al. Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood 2000; 96: 3671\u20133674.","journal-title":"Blood"},{"key":"BF2403124_CR30","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1056\/NEJM199705083361906","volume":"1336","author":"NS Young","year":"1997","unstructured":"Young NS, Maciejewski J . The pathophysiology of acquired aplastic anemia. N Engl J Med 1997; 1336: 1365\u20131372.","journal-title":"N Engl J Med"},{"key":"BF2403124_CR31","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1046\/j.1365-2141.1998.00920.x","volume":"102","author":"JJ Molldrem","year":"1998","unstructured":"Molldrem JJ, Jiang YZ, Stetler-Stevenson M, Mavroudis D, Hensel N, Barrett AJ . Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles. Br J Haematol 1998; 102: 1314\u20131322.","journal-title":"Br J Haematol"},{"key":"BF2403124_CR32","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood.V84.5.1620.1620","volume":"84","author":"MV Dhodapkar","year":"1994","unstructured":"Dhodapkar MV, Li CY, Lust JA, Tefferi A, Phyliky RL . Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood 1994; 84: 1620\u20131627.","journal-title":"Blood"},{"key":"BF2403124_CR33","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1548::AID-CNCR16>3.0.CO;2-Y","volume":"79","author":"DH Biesma","year":"1997","unstructured":"Biesma DH, van den Tweel JG, Verdonck LF . Immunosuppressive therapy for hypoplastic myelodysplastic syndrome. Cancer 1997; 79: 1548\u20131551.","journal-title":"Cancer"},{"key":"BF2403124_CR34","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ajh.2830410425","volume":"41","author":"T Sugawara","year":"1992","unstructured":"Sugawara T, Endo K, Shishido T, Sato A, Kameoka J, Fukuhara O et al. T cell-mediated inhibition of erythropoiesis in myelodysplastic syndromes. Am J Hematol 1992; 41: 304\u2013305.","journal-title":"Am J Hematol"},{"key":"BF2403124_CR35","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/0145-2126(91)90028-R","volume":"15","author":"MA Smith","year":"1991","unstructured":"Smith MA, Smith JG . The occurrence subtype and significance of haemopoietic inhibitory T cells (HIT cells) in myelodysplasia: an in vitro study. Leukemkia Res 1991; 15: 597\u2013601.","journal-title":"Leukemkia Res"},{"key":"BF2403124_CR36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1046\/j.1365-2141.2001.02561.x","volume":"112","author":"Y Saunthararajah","year":"2001","unstructured":"Saunthararajah Y, Molldrem JL, Rivera M, Williams A, Stetler-Stevenson M, Sorbara L et al. Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features. Br J Haematol 2001; 112: 195\u2013200.","journal-title":"Br J Haematol"},{"key":"BF2403124_CR37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1365-2141.1988.tb04194.x","volume":"68","author":"A Tichelli","year":"1988","unstructured":"Tichelli A, Gratwohl A, Wuersch A, Nissen C, Speck B . Antilymphocyte globulin for myelodysplastic syndrome. Br J Haematol 1988; 68: 139\u2013140.","journal-title":"Br J Haematol"},{"key":"BF2403124_CR38","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1046\/j.1365-2141.1997.4423249.x","volume":"99","author":"JJ Molldrem","year":"1997","unstructured":"Molldrem JJ, Caples M, Mavroudis D, Plante M, Young NS, Barrett AJ . Antithymocyte globulin for patients with myelodysplastic syndrome. Br J Haematol 1997; 99: 699\u2013705.","journal-title":"Br J Haematol"},{"key":"BF2403124_CR39","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1046\/j.1365-2141.1998.00551.x","volume":"100","author":"A Jonasova","year":"1998","unstructured":"Jonasova A, Neuwirtova R, Cermak J, Vozobulova V, Mocikova K, Siskova M et al. Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. Br J Haematol 1998; 100: 304\u2013309.","journal-title":"Br J Haematol"},{"key":"BF2403124_CR40","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1182\/blood.V99.9.3129","volume":"99","author":"JP Maciejewski","year":"2002","unstructured":"Maciejewski JP, Risitano A, Sloand EM, Nunez O, Young NS . Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia. Blood 2002; 99: 3129\u20133133.","journal-title":"Blood"},{"key":"BF2403124_CR41","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1182\/blood.V86.8.2938.2938","volume":"86","author":"A Raghavachar","year":"1995","unstructured":"Raghavachar A, Janssen JW, Schrezenmeier H, Wagner B, Bartram CR, Schulz AS et al. Clonal hematopoiesis as defined by polymorphic X-linked loci occurs infrequently in aplastic anemia. Blood 1995; 86: 2938\u20132947.","journal-title":"Blood"},{"key":"BF2403124_CR42","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1034\/j.1600-0609.2000.90150.x","volume":"64","author":"Y Mortazavi","year":"2000","unstructured":"Mortazavi Y, Chopra R, Gordon-Smith EC, Rutherford TR . Clonal patterns of X-chromosome inactivation in female patients with aplastic anaemia studies using a novel reverse transcription polymerase chain reaction method. Eur J Haematol 2000; 64: 385\u2013395.","journal-title":"Eur J Haematol"},{"key":"BF2403124_CR43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-0609.1996.tb01647.x","volume":"60","author":"G Socie","year":"1996","unstructured":"Socie G . Could aplastic anaemia be considered a pre-pre-leukaemic disorder? Eur J Haematol Suppl 1996; 60: 60\u201363.","journal-title":"Eur J Haematol Suppl"},{"key":"BF2403124_CR44","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1046\/j.1365-2141.2000.01868.x","volume":"108","author":"F Sole","year":"2000","unstructured":"Sole F, Espinet B, Sanz GF, Cervera J, Calasanz MJ, Luno E et al. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Espanol de Citogenetica Hematologica. Br J Haematol 2000; 108: 346\u2013356.","journal-title":"Br J Haematol"},{"key":"BF2403124_CR45","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0145-2126(00)00056-4","volume":"24","author":"T de Souza Fernandez","year":"2000","unstructured":"de Souza Fernandez T, Ornellas MH, Otero de Carvalho L, Tabak D, Abdelhay E . Chromosomal alterations associated with evolution from myelodysplastic syndrome to acute myeloid leukemia. Leukemia Res 2000; 24: 839\u2013848.","journal-title":"Leukemia Res"},{"key":"BF2403124_CR46","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/ajh.2830460404","volume":"46","author":"P Bernasconi","year":"1994","unstructured":"Bernasconi P, Alessandrino EP, Boni M, Bonfichi M, Morra E, Lazzarino M et al. Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival. Am J Hematol 1994; 46: 270\u2013277.","journal-title":"Am J Hematol"},{"key":"BF2403124_CR47","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/BF01728788","volume":"60","author":"L Vila","year":"1990","unstructured":"Vila L, Charrin C, Archimbaud E, Treille-Ritouet D, Fraisse J, Felman P et al. Correlations between cytogenetics and morphology in myelodysplastic syndromes. Blut 1990; 60: 223\u2013227.","journal-title":"Blut"},{"key":"BF2403124_CR48","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1182\/blood.V98.13.3513","volume":"98","author":"JP Maciejewski","year":"2001","unstructured":"Maciejewski JP, Follmann D, Nakamura R, Saunthararajah Y, Rivera CE, Simonis T et al. Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH\/aplastic anemia syndrome. Blood 2001; 98: 3513\u20133519.","journal-title":"Blood"},{"key":"BF2403124_CR49","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/blood.V85.12.3367.bloodjournal85123367","volume":"85","author":"NS Young","year":"1995","unstructured":"Young NS, Barrett AJ . The treatment of severe acquired aplastic anemia. Blood 1995; 85: 3367\u20133377.","journal-title":"Blood"},{"key":"BF2403124_CR50","doi-asserted-by":"publisher","first-page":"4823","DOI":"10.1073\/pnas.82.14.4823","volume":"82","author":"RF Hunter","year":"1985","unstructured":"Hunter RF, Mold NG, Mitchell RB, Huang AT . Differentiation of normal marrow and HL60 cells induced by antithymocyte globulin. Proc Natl Acad Sci USA 1985; 82: 4823\u20134827.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2403124_CR51","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1365-2141.1994.tb05091.x","volume":"88","author":"AT Huang","year":"1994","unstructured":"Huang AT, Mold NG . The role of CD45RO in antithymocyte globulin's stimulation of primitive haemopoietic cells. Br J Haematol 1994; 88: 643\u2013646.","journal-title":"Br J Haematol"},{"key":"BF2403124_CR52","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1046\/j.1365-2141.2000.01853.x","volume":"108","author":"SB Killick","year":"2000","unstructured":"Killick SB, Marsh JC, Gordon-Smith EC, Sorlin L, Gibson FM . Effects of antithymocyte globulin on bone marrow CD34+ cells in aplastic anaemia and myelodysplasia. Br J Haematol 2000; 108: 582\u2013591.","journal-title":"Br J Haematol"},{"key":"BF2403124_CR53","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1182\/blood.V79.10.2540.bloodjournal79102540","volume":"79","author":"E Gluckman","year":"1992","unstructured":"Gluckman E, Esperou-Bourdeau H, Baruchel A, Boogaerts M, Briere J, Donadio D et al. Multicenter randomized study comparing cyclosporine-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. Blood 1992; 79: 2540\u20132546.","journal-title":"Blood"},{"key":"BF2403124_CR54","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1182\/blood.V93.7.2191","volume":"93","author":"J Marsh","year":"1999","unstructured":"Marsh J, Schrezenmeier H, Marin P, Ilhan O, Ljungman P, McCann S et al. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood 1999; 93: 2191\u20132195.","journal-title":"Blood"},{"key":"BF2403124_CR55","doi-asserted-by":"publisher","first-page":"156","DOI":"10.7326\/0003-4819-137-3-200208060-00007","volume":"137","author":"JJ Molldrem","year":"2002","unstructured":"Molldrem JJ, Leifer E, Bahceci E, Saunthararajah Y, Rivera M, Dunbar C et al. Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes. Ann Intern Med 2002; 137: 156\u2013163.","journal-title":"Ann Intern Med"},{"key":"BF2403124_CR56","doi-asserted-by":"crossref","first-page":"315a","DOI":"10.1182\/blood.V84.1.315.315","volume":"84","author":"S Mineishi","year":"1994","unstructured":"Mineishi S, Filippa D, Childs B, Castro-Malaspina H . Hypoplastic myelodysplastic syndrome (MDS): clinical, hematologic, and pathologic observations in 36 cases. Blood 1994; 84: 315a.","journal-title":"Blood"},{"key":"BF2403124_CR57","first-page":"28a","volume":"80","author":"AF List","year":"1992","unstructured":"List AF, Glinsmann-Gibson B, Spier C, Taetle R In vitro and in vivo response to cyclosporin-A in myelodysplastic syndromes (MDS): identification of a hypocellular subset responsive to immune suppression. Blood 1992; 80: 28a.","journal-title":"Blood"},{"key":"BF2403124_CR58","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1046\/j.1365-2141.2003.04136.x","volume":"120","author":"SB Killick","year":"2003","unstructured":"Killick SB, Mufti G, Cavenagh JD, Mijovic A, Peacock JL, Gordon-Smith JC, Taetle R . A pilot study of antithymocyte globulin (ATG) in the treatment of patients with \u2018low-risk\u2019 myelodysplasia. Br J Haematol 2003; 120: 679\u2013684.","journal-title":"Br J Haematol"},{"key":"BF2403124_CR59","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/00005792-198801000-00003","volume":"67","author":"L Bielory","year":"1988","unstructured":"Bielory L, Gascon P, Lawley TJ, Young NS, Frank MM . Human serum sickness: a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure. Medicine 1988; 67: 40\u201357.","journal-title":"Medicine"},{"key":"BF2403124_CR60","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1182\/blood.V79.10.2566.2566","volume":"79","author":"K Doney","year":"1992","unstructured":"Doney K, Pepe M, Storb R, Bryant E, Anasetti C, Appelbaum FR et al. Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone. Blood 1992; 79: 2566\u20132571.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403124","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T15:06:44Z","timestamp":1734102404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8,21]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,11,1]]}},"alternative-id":["BF2403124"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403124","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8,21]]},"assertion":[{"value":"12 May 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}